<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>IRB USI</provider_name><provider_url>https://irb.usi.ch/it/</provider_url><author_name>AD_Dave</author_name><author_url>https://irb.usi.ch/it/author/ad_dave/</author_url><title>INNOCHEM: targeting chemokine / receptor interactions - IRB USI</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="xaKrSp4k7F"&gt;&lt;a href="https://irb.usi.ch/it/news/innochem-targeting-chemokine-receptor-interactions/"&gt;INNOCHEM: targeting chemokine / receptor interactions&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://irb.usi.ch/it/news/innochem-targeting-chemokine-receptor-interactions/embed/#?secret=xaKrSp4k7F" width="600" height="338" title="&#x201C;INNOCHEM: targeting chemokine / receptor interactions&#x201D; &#x2014; IRB USI" data-secret="xaKrSp4k7F" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script&gt;
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://irb.usi.ch/wp-includes/js/wp-embed.min.js
&lt;/script&gt;
</html><description>on July 17, 2006 Dr. Mariagrazia Uguccioni, at the IRB, is the scientific coordinator of the European project INNOCHEM that aims to develop innovative chemokine-based therapeutic strategies for autommunity and chronic inflammation. The five year project involves 22 participants from 11 countries who have made major contributions to chemokine discovery, and to the construction of [&hellip;]</description></oembed>
